GSK plc (GLAXF) cash flow statement

GLAXFOTCPharmaceutical PreparationsAlso trades as GSK

Financials through fiscal 2025, year ended Dec 31, 2025Score 9/30

$24.74+0.30 (+1.21%)

Close on Oct 19, 2026Market cap $53.38BP/E 6.7Yield –

GSK plc cash flow statement

AnnualQuarterlyTTM

GBP USD

Millions of GBP, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31	FY 2020 2020-12-31	FY 2019 2019-12-31	FY 2018 2018-12-31	FY 2017 2017-12-31	FY 2016 2016-12-31	FY 2015 2015-12-31
Depreciation & Amortization	2,314	2,551	2,294	2,147	2,122	2,050	2,334	1,856	1,922	1,774	1,630
Stock-Based Compensation	374	344	307	346	343	337	365	360	333	319	368
Change in Accounts Receivable	-613	298	-794	-158	-780	-279	-32	-429	-287	-188	98
Change in Inventory	-140	-294	-424	-269	51	100	300	51	-461	70	-111
Change in Accounts Payable	131	-179	-15	494	229	132	263	131	11	96	40
Operating Cash Flow	7,741	6,554	6,768	7,403	7,952	8,441	8,020	8,421	6,918	6,497	2,569
Capital Expenditures	-1,348	-1,399	-1,314	-1,143	-950	-989	-1,265	-1,344	-1,545	-1,543	-1,380
Acquisitions	-1,692	-805	-1,457	-3,108	0	0	-3,571	0	–	17	-3,203
Sale of Property, Plant & Equipment	24	65	28	146	132	49	95	168	281	98	72
Investing Cash Flow	-4,233	-1,229	-1,595	-8,772	-1,777	2,161	-5,354	-1,553	-1,443	-1,269	6,037
Dividends Paid	-2,564	-2,444	-2,247	-3,467	-3,999	-3,977	-3,953	-3,927	-3,906	-4,850	-3,874
Share Repurchases	-1,377	0	0	–	–	–	–	–	–	–	–
Stock Issued	15	20	10	25	21	29	51	74	56	89	73
Financing Cash Flow	-3,685	-4,726	-5,641	823	-7,589	-10,132	-1,840	-6,389	-6,380	-6,392	-7,103
Foreign Exchange Rate Adjustments	-19	-54	-99	152	-29	-39	-82	8.00	-100	283	-45
Free Cash Flow	6,393	5,155	5,454	6,260	7,002	7,452	6,755	7,077	5,373	4,954	1,189
Income Taxes Paid	1,202	1,307	1,328	1,310	1,291	1,655	1,512	1,326	1,340	1,609	2,062

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Dec 31, 2025

Profitability, FY2025

Gross margin: 72.4%
Operating margin: 24.3%
Net margin: 17.5%
Return on equity, FY2025: 38.0%

Financial strength

Current ratio: 0.82
Debt to equity: 1.08
Debt to assets: 29.0%
Cash to current liabilities: 15.9%

Valuation

P/E ratio: 6.7
Price to sales: 1.22
Price to book: 2.43
Dividend yield: –